alexa Viruses That Can Cure, When Antibiotics Fail...
ISSN: 1948-5948

Journal of Microbial & Biochemical Technology
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Short Communication

Viruses That Can Cure, When Antibiotics Fail...

Verbeken G1-3*, Pirnay JP1, Lavigne R4, Ceulemans C3, Vos D1 and Huys I2,5

1Laboratory for Molecular and Cellular Technology, Burn Wound Centre, Queen Astrid Military Hospital, Bruynstraat, Brussel, Belgium

2Faculty of Pharmaceutical and Pharmacological Sciences, KU Leuven, Herestraat, Leuven, Belgium

3Department of Behavioural Sciences, Royal Military Academy, Renaissancelaan, Brussel, Belgium

4Laboratory of Gene Technology, KU Leuven, Leuven, Belgium

5Centre for Intellectual Property Rights, KU Leuven, Minderbroedersstraat, Leuven, Belgium

*Corresponding Author:
Verbeken G
Laboratory for Molecular and Cellular Technology
Burn Wound Centre, Queen Astrid Military Hospital
Bruynstraat, Brussel, Belgium
Tel: + 32 2 264 4856
E-mail: [email protected]

Received Date: December 03, 2015; Accepted Date: December 15, 2015; Published Date: December 22, 2015

Citation: Verbeken G, Pirnay JP, Lavigne R, Ceulemans C, De Vos D, et al. (2016) Viruses That Can Cure, When Antibiotics Fail…. J Microb Biochem Technol 8: 021- 024. doi:10.4172/1948-5948.1000257

Copyright: © 2015 Verbeken G, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

 

Abstract

Resistance of bacteria to antibiotics just keeps growing. Industry’s antibiotic pipeline is running dry. Before the pharmaceutical development of antibiotics, natural bacteriophages (=bacterial viruses) were commercialised and used to kill pathogenic bacteria. This therapeutic application of natural bacteriophages was called “bacteriophage therapy”. Today, countries like Poland, Georgia and Russia are still practising bacteriophage therapy. The European Union and “modern” medicine as a whole needs an urgent return of bacteriophage therapy as part of its armamentarium to fight bacterial resistance to antibiotics. This paper reflects on the issue and proposes a European regulatory frame that could fit the re-introduction of bacteriophage therapy without losing sight of safety, quality and efficacy aspects.

Keywords

Share This Page

Additional Info

Loading
Loading Please wait..
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords